- 商品介绍
- 规格参数
- 包装参数
Biochem/physiol Actions
GHP-88309 is an orally available non-nucleoside paramyxovirus polymerase inhibitor with broad-spectrum anti-paramyxoviral activity (EC50 in μM= 0.4/HPIV3-JS, 0.8/HPIV3-5F6, 2/SeV-F1R-eGF, 0.6/MeV/Alaska.USA 16.00, 0.4/CDV-5804p) and little cytoxicity (CC50 >20μM). GHP-88309 potently inhibits the replication of HPIV1 isolate 5F6 and HPIV3 isolates 10L3 & 9R4 in 3D-ALI-HBTEC human airway organoids (EC50 = 280,90, 105 nM, respectively) in 3D-ALI-HBTECs. HPIV3 and provides complete protection against lethal Sendai virus infection in mice (150 mg/kg bid. po. starting at time of infection or 48 hrs after), a murine surrogate model of human HPIV3 disease.
Orally available non-nucleoside paramyxovirus polymerase inhibitor with broad-spectrum anti-paramyxoviral activity in vitro and in vivo.
| Quality Segment | 100 |
| assay | ≥98% (HPLC) |
| form | powder |
| color | white to beige |
| solubility | DMSO: 2 mg/mL, clear |
| storage temp. | 2-8°C |
| SMILES string | FC1=C(C(N)=O)C(C2=C(C=CN=C3)C3=CC=C2)=CC=C1 |
| InChI key | OLNVLPGIADWVKU-UHFFFAOYSA-N |
| 长度(mm) | |
| 宽度(mm) | |
| 高度(mm) | |
| 重量(kg) |
-
¥ 2622.09
-
¥ 1302.89
-
¥ 2019.57
-
¥ 9207.92
-
询价
-
询价
-
询价
-
¥ 3442.25
-
询价
-
询价
-
询价
-
询价
-
询价
-
¥ 2666.57
-
询价
-
¥ 745.60
-
¥ 4020.77
-
¥ 5061.38
-
¥ 2406.69
-
¥ 5804.96
微信小程序
7X24小时在线咨询